Cargando…
Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials
BACKGROUND: Cardiac magnetic resonance (CMR) T1 mapping has been used to characterize myocardial diffuse fibrosis. The aim of this study is to determine the reproducibility and sample size of CMR fibrosis measurements that would be applicable in clinical trials. METHODS: A modified Look-Locker with...
Autores principales: | Liu, Songtao, Han, Jing, Nacif, Marcelo S, Jones, Jacquin, Kawel, Nadine, Kellman, Peter, Sibley, Christopher T, Bluemke, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552738/ https://www.ncbi.nlm.nih.gov/pubmed/23272704 http://dx.doi.org/10.1186/1532-429X-14-90 |
Ejemplares similares
-
Sample size calculation for clinical trials using cardiac magnetic resonance partition coefficient and extracellular volume fraction for the assessment of diffuse myocardial fibrosis
por: Liu, Songtao, et al.
Publicado: (2013) -
T1 mapping of the myocardium: Intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region
por: Kawel, Nadine, et al.
Publicado: (2012) -
T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA
por: Kawel, Nadine, et al.
Publicado: (2012) -
Myocardial T1 and extracellular volume fraction mapping at 3 tesla
por: Lee, Jason J, et al.
Publicado: (2011) -
Myocardial T1 mapping and determination of partition coefficients at
3 tesla: comparison between gadobenate dimeglumine and gadofosveset
trisodium
por: Nacif, Marcelo Souto, et al.
Publicado: (2018)